Allegro and American Regent sign exclusive licensing deal for Synoglide, a novel osteoarthritis device in animal health, valued at up to $35 million
Liege, Belgium and Shirley, NY – 25 November 2025 (08:30 CET) – Allegro NV, a biomedical company developing transformative nanotechnology-based devices for […]
